The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


AZN ASTRAZENECA PLC ORD SHS $0.25

ASTRAZENECA  Currency  GBX  Premium Equity Commercial Companies



 Page 3 of 11

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next |

Time/Date Code Headline Source Impact
07:00 31-Jul-2014 AZN Second Quarter & Half Year Results 2014 RNS -1.27% Down
09:00 30-Jul-2014 AZN Notice of Results RNS -0.79% Down
07:00 30-Jul-2014 AZN STRATEGIC RESPIRATORY TRANSACTION WITH ALMIRALL RNS -0.79% Down
15:30 01-Jul-2014 AZN Total Voting Rights RNS +1.42% Up
12:00 01-Jul-2014 AZN Director/PDMR Shareholding RNS +1.42% Up
14:00 26-Jun-2014 AZN Director/PDMR Shareholding RNS -0.72% Down
07:00 26-Jun-2014 AZN FDA Advisory Committee votes on olaparib RNS -0.72% Down
17:30 24-Jun-2014 AZN Publication of Prospectus RNS -1.26% Down
11:00 18-Jun-2014 AZN Holding(s) in Company RNS +0.48% Up
10:00 18-Jun-2014 AZN Director/PDMR Shareholding RNS +0.48% Up
10:00 18-Jun-2014 AZN Director/PDMR Shareholding RNS +0.48% Up
15:00 13-Jun-2014 AZN Clarification of AXA shareholding in AstraZeneca RNS +0.56% Up
07:00 13-Jun-2014 AZN FDA AdCom recommends no CV trial for PAMORA class RNS +0.56% Up
07:00 12-Jun-2014 AZN ASTRAZENECA IN-LICENSES SYNAIRGEN'S SNG001 RNS +1.05% Up
07:00 11-Jun-2014 AZN AZ TO PRESENT NEW DATA AT ADA RNS +1.31% Up
14:30 03-Jun-2014 AZN ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ASCO RNS +0.93% Up
14:00 02-Jun-2014 AZN Blocklisting Interim Review RNS +0.93% Up
13:30 02-Jun-2014 AZN Total Voting Rights RNS +0.93% Up
16:14 27-May-2014 AZN Form 8.3 - Astrazeneca Plc BZN -0.22% Down
15:07 27-May-2014 AZN Form 8.3 - AstraZeneca Plc BZN -0.22% Down

 Page 3 of 11

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next |

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released, including the day of the release of the news
y = instrument's latest 7 closing prices before the news was released

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank " - " next to the line indicating the RNS issue.


ASTRAZENECA share - news analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds